S. 1302 · 119th Congress · Health
Increasing Transparency in Generic Drug Applications Act
- IntroducedApr 3, 2025 Done
- CommitteeReferred to Health, Education, Labor, and Pensions Current stage
- Senate floorNot yet Not reached yet
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.Who lobbies on it
10 organizations · 44 filings · Q2 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Viatris (mylan, Inc)
6 of 6 quarters
“Issues related to drug pricing; pharmaceutical supply chain; modernization of prescribing information for physicians and pharmacists; Increasing Transparency in Generic Drug Applications, S.1302 and H.R. 1843; Part D Formulary Design and Generic Drug Testing”
-
Association for Accessible Medicines
5 of 6 quarters
“Prescription Drug Costs. H.R.1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. S.1302: Increasing Transparency in Generic Drug Applications Act. Drug Shortages. H.R.4191/S.1784: Mapping Americas Pharmaceutical Supply (MAPS) Act. H.R.4132/S.2027: Prescription…”
-
Blue Cross Blue Shield of Michigan
5 of 6 quarters
“Issues: Generics access; Prescription Drug Cost; PBM Reform and Prescription Drug Policy Bills: S.3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1096 - Preserve Access to Affordable…”
7 more organizations, every filingPROUpgrade
Organizations that named S. 1302 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.
Actions
2 actions · newest first- Apr 3, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Apr 3, 2025Introduced in Senate
What members said about it
-
U.S. Senators Maggie Hassan (D-NH), Rand Paul (R-KY), John Hickenlooper (D-CO), and Mike Lee (R-UT) reintroduced bipartisan legislation to streamline the approval process for generic drugs, which will help generics enter the market more…
“Skyrocketing prescription drug prices are forcing too many Granite Staters to choose between their health and their financial security.”
-
Social Security Fairness Act Becomes Law
Yesterday, President Joe Biden signed into law H.R. 82 The Social Security Fairness Act, legislation that repeals the Windfall Elimination Provision (WEP) and Government Pension Offset (GPO).
“I have been working on the Social Security Fairness Act for as long as I’ve been representing Alaska in the United States Senate.”